Klinik für Strahlentherapie – Radioonkologie


Gadalla R, Hassan H, Ibrahim SA, Abdullah MS, Gaballah A, Greve B, El-Deeb S, El-Shinawi M, Mohamed MM: Tumor microenvironmental plasmacytoid dendritic cells contribute to breast cancer lymph node metastasis via CXCR4/SDF-1 axis. Breast Cancer Res Treat 10. doi: 10.1007/s10549-019-05129-8, 2019

Troschel FM, Böhly N, Borrmann K, Braun T, Schwickert A, Kiesel L, Eich HT, Götte M, Greve B: miR-142-3p attenuates breast cancer stem cell characteristics and decreases radioresistance in vitro. Tumor Biology DOI: 10.1177/1010428318791887, 2018

Ibrahim SA, Gadalla R, El-Ghonaimy E, Samir O, Mohamed HT, Hassan H, Greve B, El-Shinawi-M, Mohamed MM, Götte M: Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3 and Notch signaling pathways. Molecular Cancer 16 (1): 57, 2017

Min J, Yao B, Ketelhut S, Greve B, Kemper B: Simple and fast spectral domain algorithm for quantitiative phase imaging of living cells with digital holographic microscopy. Optics Letters 42 (2): 227-230, 2017

Viola M, Brüggemann K, Karousou E, Caon I, Carava E, Vigetti D, Greve B, Stock C, De Luca G, Passi A, Götte M: MDA-MB-231 breast cancer cell viability, motility and matrix adhesion are regulated by complex interplay of heparin sulfate, chondroitin-/dermatan sulfate and hyaluronan biosynthesis. Glycoconj J 34: 411-420, 2017

Turko NA, Isbach M, Ketelhut S, Greve B, Schnekenburger J, Shaked NT, Kemper B: Multi-modal and photothermal quantitative phase imaging of living cells with nanoparticles in a combined setup. Proc. of SPIE-OSA 10414, 104140E, 2017

Eggers JC, Martino V, Reinbold R, Schäfer SD, Kiesel L, Starzinski-Powitz A, Schüring AN, Kemper B, Greve B*, Götte M*: microRNA mir-200b affects proliferation, invasiveness and stemness of endometriotic cells by trageting ZEB1, ZEB2 and KLF4. Reproductive BioMedicine Online doi: 10.1016/j.rbmo, 2016 (gemeinsame Letztautoren)

Nemes A, Fortmann T, Poeschke S, Greve B, Prevedollo D, Santacroce A, Stummer W, Senner V, Ewelt C: 5-ALA Fluorescence in Native Pituitary Adenoma Cell Lines: Resection Control and Basis for Photodynamic Therapy (PDT)?. PLosOne 11 (9): e0161364, 2016

Viola M, Brüggemann K, Karousou E, Caon I, Caravá E, Vigetti D, Greve B, Stock C, De Luca G, Passi A, Götte M: MDA-MB-231 breast cancer cell viability, montility and matrix adhesion are regulated by a complex interplay of heparin sulfate, chondroitin-/dermantan sulfate and hyaluronan biosynthesis. Glycoconjugate Journal 2016 DOI 10.1007

Spaniol K, Metzger M, Roth M, Greve B, Mertsch S, Geerling G, Schrader S: Engineering of a secretory active three-dimensional lacrimal gland construct on the basis of decellularized lacrimal gland tissue. Tissue engineering Part A, 2015 E-Pub

Sterzing F, Brunner T, Ernst I, Baus WW, Greve B, Herfarth K, Guckenberger M: Stereotactic Body Radiotherapy (SBRT) for liver tumors: priciple and practical guidelines - by the DEGRO working group "Stereotactic radiotherapy". Strahlentherapie und Onkologie, 2014 E-pup

Bernemann C, Hülsewig C, Ruckert C, Schäfer S, Blümel L, Hempel G, Götte M, Greve B, Barth PJ, Kiesel L, Liedke C: Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer doen not rely on WNT signaling. Molecular Cancer 13, 2014

Weidner J, Cassens U, Göhde W, Wüllenweber J, Greve B: A new triplex real time PCR which distinuishing between MRSA, MSSA and mecA coagulase negative strains by means of melting point analysis using SYTO9. Clinical Laboratory 59: 795-804, 2013

Ibrahim S, Hassan H, Vilardo L, Schneider C, Kelsch R, Kiesel L, Eich HT, Reinbold R, Greve B*, Götte M*: Syndecan-1 (CD138) modulates triple negative breast cancer stem cell properties via regulation of IL-6-mediated STAT3 signaling. PlosOne 8 (12), e85737, 2013 ( *shared corresponding authors)

Adammek M*, Greve B*, Kässens N, Schneider C, Brüggemann K, Kampmeyer C, Schüring A, Starzinski-Powitz A, Kiesel L, Götte M,: microRNA miR-145 inhibits proliferation, invasiveness and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factors. Fertility and Sterility, 2013 (* gemeinsame Erstautoren) E-pup

Hassan H, Greve B, Pavao MSG, Kiesel L, Ibrahim SA, Götte M: Syndecan-1 modulates beta-integrin-and IL-6-dependent functions in breast cancer cell adhesion, migration and resistance to irradiation. FEBS Journal, 2013 E-pup

Greve B, Sheikh-Mounessi F, Ernst I, Götte M, Eich HT: Survivin, a target to modulate the radiosensitivity of Ewing´s sarcoma. Strahlentherapie und Onkologie, 188 (11): 1038-1047, 2012

Greve B, Bölling T, Amler S, Rössler U, Gomolka M, Mayer C, Popanda O, Dreffke K, Rickinger A, Fritz E, Eckardt-Schupp F, Sauerland M, Braselmann H, Sauter W, Illig T, Riesenbeck D, Könemann S, Willich N, Mörtl S, Eich HT, Schmezer P: Evulation of Different Biomarkers to Predict Individual Radiosensitivity in an Inter-Laboratory Comparison - Lessons for Future Studies. PLoSOne, 7 (10): e47185, 2012

Weidner J, Cassens U, Göhde W, Wüllenweber J, Greve B: A new Real Time PCR which distinguishing between MRSA, MSSA and mecA coagulase negative Strains by means of Melting Point Analysis using SYTO9. Clinical Laboratory 2012 in press

Greve B, Spaniol K, Eich HT, Götte M: Flow cytometry in cancer stem cell analysis and sorting. Cytometry A 81 (4): 284-93, 2012

Schneider C, Kässens N, Greve B, Hassan H, Schüring A, Starzinski-Powitz A, Kiesel L, Seidler D, Götte M: Targeting of Syndecan-1 by microRNAmiR-10b modulates invasiveness of endometriotic cells via dysregulation of the proteolytic milieu and IL-6 secretion. Sterility and Fertility, 2012 in press

Przibilla S, Dartmann S, Vollmer A, Ketelhut S, Greve B, von Bally G, Kemper B: Sensing dynamic cytoplasm refractive index changes of different cells with quantitative phase microscopy using incorporated microspheres as optical probes. Journal of Biomedical Optics 2012 E-pub

Di Marco G, Rustemyer P, Brand M, Koch R, Kentrup D, Grabner A, Greve B, Wittkowski W, Pavenstädt H, Hausberg M, Reuter S, Lang D: Circulating Endothelial Progenitor Cells in Kidney Transplant Patients. PLOS one 6 (9): e24046, 2011 E-pub

Meyer C, Popanda O, Greve B, Fritz E, Illig T, Eckhardt-Schupp F, Gomolka M, Benner A, Schmezer P, A radiation-induced gene expression signature as a tool to predict acute radiotherapy-induced side effects. Cancer Letters, 2011 online

Götte M*, Greve B*, Kelsch R*, Müller-Uthoff H, Weiss K, Masouleh BH, Kiesel L, Buchweitz O:The adult stem cell marker Mushashi-1 modulates endometrial Carcinoma cell cycle progression and apoptosis via Notch-1 and p21WAF1/CIP1. British Journal Cancer 2011 online; *gemeinsame Erstautoren

Weidner J, Cassens U, Göhde W, Sibrowsky W, Odaibo G, Olaleye D, Reichelt D, Greve B: A world wide applicable Flow Cytometry based method for the detection of HIV-1 proviral DNA. Journal of Virological Methods 2011 online

Bölling T, Kolkmeyer A, Greve B, Ernst I, Willich N, Könemann S, Heterogeneity of radiation- and TNF-alpha-induced programmed cell death in carcinoma, sarcoma and lymphoma cell lines. Anticancer Research 30 (7): 2857-61, 2010

Wesbur S, Lanvers-Karminsky C, Duran-Seuberth I, Bölling T, Schäfer KL, Braun Y, Willich N, Greve B: Association of telomerase activity with radio- and chemosensitivity in neuroblastomas. Radiation Oncology 5 (1): 66, 2010

Agelopoulos K, Greve B, Schmidt H, Pospisil H, Kurtz, S, Bartkowiak K, Andreas, A, Wieczorek M, Korsching E, Buerger H, Brandt B: Selective regain of egfr gene copies in CD44+/CD24-/low breast cancer cellular model MDA-MB-468. BMC Cancer 10, online , 2010

Greve B, Weidner J, Cassens U, Odaibo G, Olaleye D, Sibrowski W, Reichelt D, Nasdala I, Göhde W: A New affordable Flow Cytometry Based Method to Measure HIV-1 Viral Load.
Cytometry Part A, 75 (3): 199-206, 2009

Greve B, Dreffke K, Rickinger A, Könemann S, Fritz E, Eckardt-Schupp F, Amler S, Sauerland C, Braselmann H, Sauter W, Illig T, Schmezer P, Gomolka M, Willich N, Bölling T: Multicentric investigation of ionising radiation-induced cell death as a predictive parameter of individual radiosensitivity. Apoptosis, 14 (2): 226-235, 2009

Rustemeyer P, Greve B, Stehling M, Wittkowski W: Flow Cytometric Identification, Enumeration, Purification and Expension of CD133+ and VEGF-R2+ Endothelial Progenitor Cells from Peripheral Blood. Journal of Immunoassay and Immunochemistry, 28 (1): 13-23, 2007

Greve B, Beller C, Cassens U, Sibrowski W, Göhde, W: The impact of erythrocyte lysing procedures on the recovery of hematopoietic progenitor cells in flow cytometric analysis. Stem Cells, 24 (3): 793-799, 2006

Severin E*, Greve B*, Pascher E, Wedemeyer N, Hacker-Klom U, Silling G, Kienast J, Willich N, Göhde W: Evidence for predictive validity of blood assays to evaluate individual radiosensitivity. International Journal of Radiation Oncology Biology Physics 64 (1): 242-250, online published 2005 (* gemeinsame Erstautoren)


Leiter Strahlenbiologie

Prof. Dr. Burkhard Greve
E-Mail: greveb(at)­uni-muenster(dot)­de